Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-004200

Chief Scientific Officer sold 13,673 shares at $8.22 ($112,367)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Barone Francesca Chief Scientific Officer 2025-01-08 Sale −13,673 $8.22 $112,367 124,207 D: show line 1 in the form
Open-market sales · 13,673 sh · avg $8.22 · $112,367
Loading xslF345X05/ownership.xml…